222 related articles for article (PubMed ID: 12939285)
1. Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis.
Sappington RM; Pearce DA; Calkins DJ
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3725-31. PubMed ID: 12939285
[TBL] [Abstract][Full Text] [Related]
2. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography.
Groh J; Stadler D; Buttmann M; Martini R
Acta Neuropathol Commun; 2014 May; 2():54. PubMed ID: 24887158
[TBL] [Abstract][Full Text] [Related]
4. Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons.
Weimer JM; Custer AW; Benedict JW; Alexander NA; Kingsley E; Federoff HJ; Cooper JD; Pearce DA
Neurobiol Dis; 2006 May; 22(2):284-93. PubMed ID: 16412658
[TBL] [Abstract][Full Text] [Related]
5. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
Luiro K; Kopra O; Lehtovirta M; Jalanko A
Hum Mol Genet; 2001 Sep; 10(19):2123-31. PubMed ID: 11590129
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage.
Dannhausen K; Möhle C; Langmann T
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30042155
[TBL] [Abstract][Full Text] [Related]
7. Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.
Zhong Y; Mohan K; Liu J; Al-Attar A; Lin P; Flight RM; Sun Q; Warmoes MO; Deshpande RR; Liu H; Jung KS; Mitov MI; Lin N; Butterfield DA; Lu S; Liu J; Moseley HNB; Fan TWM; Kleinman ME; Wang QJ
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165883. PubMed ID: 32592935
[TBL] [Abstract][Full Text] [Related]
8. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.
Pontikis CC; Cella CV; Parihar N; Lim MJ; Chakrabarti S; Mitchison HM; Mobley WC; Rezaie P; Pearce DA; Cooper JD
Brain Res; 2004 Oct; 1023(2):231-42. PubMed ID: 15374749
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical localization of the Batten disease (CLN3) protein in retina.
Katz ML; Gao CL; Prabhakaram M; Shibuya H; Liu PC; Johnson GS
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2375-86. PubMed ID: 9344361
[TBL] [Abstract][Full Text] [Related]
10. Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth.
Cotman SL; Vrbanac V; Lebel LA; Lee RL; Johnson KA; Donahue LR; Teed AM; Antonellis K; Bronson RT; Lerner TJ; MacDonald ME
Hum Mol Genet; 2002 Oct; 11(22):2709-21. PubMed ID: 12374761
[TBL] [Abstract][Full Text] [Related]
11. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
[TBL] [Abstract][Full Text] [Related]
12. Modulating membrane fluidity corrects Batten disease phenotypes in vitro and in vivo.
Schultz ML; Tecedor L; Lysenko E; Ramachandran S; Stein CS; Davidson BL
Neurobiol Dis; 2018 Jul; 115():182-193. PubMed ID: 29660499
[TBL] [Abstract][Full Text] [Related]
13. Altered flurothyl seizure induction latency, phenotype, and subsequent mortality in a mouse model of juvenile neuronal ceroid lipofuscinosis/batten disease.
Kriscenski-Perry E; Applegate CD; Serour A; Mhyre TR; Leonardo CC; Pearce DA
Epilepsia; 2002 Oct; 43(10):1137-40. PubMed ID: 12366726
[TBL] [Abstract][Full Text] [Related]
14. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A
Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045
[TBL] [Abstract][Full Text] [Related]
15. Altered gene expression in the eye of a mouse model for batten disease.
Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
[TBL] [Abstract][Full Text] [Related]
16. Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis.
Grünewald B; Lange MD; Werner C; O'Leary A; Weishaupt A; Popp S; Pearce DA; Wiendl H; Reif A; Pape HC; Toyka KV; Sommer C; Geis C
Elife; 2017 Nov; 6():. PubMed ID: 29135436
[TBL] [Abstract][Full Text] [Related]
17. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.
Järvelä I; Sainio M; Rantamäki T; Olkkonen VM; Carpén O; Peltonen L; Jalanko A
Hum Mol Genet; 1998 Jan; 7(1):85-90. PubMed ID: 9384607
[TBL] [Abstract][Full Text] [Related]
18. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.
Xiong J; Kielian T
J Neurochem; 2013 Oct; 127(2):245-58. PubMed ID: 23919525
[TBL] [Abstract][Full Text] [Related]
19. Functional categorization of gene expression changes in the cerebellum of a Cln3-knockout mouse model for Batten disease.
Brooks AI; Chattopadhyay S; Mitchison HM; Nussbaum RL; Pearce DA
Mol Genet Metab; 2003 Jan; 78(1):17-30. PubMed ID: 12559844
[TBL] [Abstract][Full Text] [Related]
20. Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7/8 knock-in mouse model of Batten disease.
Pontikis CC; Cotman SL; MacDonald ME; Cooper JD
Neurobiol Dis; 2005 Dec; 20(3):823-36. PubMed ID: 16006136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]